COMPANY

Keylicon Biosciences

HQ: Brookline, MA source · keylicon.com ↗

Keywords: From press sources:RNA therapeutics vaccine infectious disease directed evolution

Location: Brookline, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Connect

See your connections at Keylicon Biosciences on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-04

Funding and NIH signals

NIH award NIH awarded $400K (SBIR Phase I 1R43EB038819-01A1, new, notice Sep 7, 2026); 4 NIH awards totaling $1.43M in the last 12 months. NIH RePORTER 1R43EB038819-01A1 (Sep 7, 2026)
Evidence (4 events)
- Sep 7, 2026 · NIH RePORTER 1R43EB038819-01A1
  Organization: KEYLICON BIOSCIENCES INC; City/State: BROOKLINE, MA; Project number: 1R43EB038819-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-07; FY total cost (award amount): 400000; Administering IC: National Institute of Biomedical Imaging and Bioengineering; Project title: Improving the Stability of saRNA LNP Formulations To Overcome Cold Chain Challenges; Organization type: Domestic For-Profits
- Aug 21, 2026 · NIH RePORTER 1R43DK146746-01
  Organization: KEYLICON BIOSCIENCES INC; City/State: BROOKLINE, MA; Project number: 1R43DK146746-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-21; FY total cost (award amount): 400000; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Extended In Situ Production of Glucocerebrosidase (GCase) for the Treatment of Gaucher Disease; Organization type: Domestic For-Profits
- Jul 29, 2026 · NIH RePORTER 1R43AI197306-01
  Organization: KEYLICON BIOSCIENCES INC; City/State: BROOKLINE, MA; Project number: 1R43AI197306-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-07-29; FY total cost (award amount): 314363; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Low Dose Multivalent Influenza Vaccine via Modified Self-Amplifying RNA; Organization type: Domestic For-Profits
- Jul 20, 2026 · NIH RePORTER 1R43AI197345-01
  Organization: KEYLICON BIOSCIENCES INC; City/State: BROOKLINE, MA; Project number: 1R43AI197345-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-07-20; FY total cost (award amount): 314363; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Multivalent Vaccine Against Lyme Disease via Modified Self-Amplifying RNA; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals